Considering the lack of prospective data, we analyzed the oncological outcome and long-term toxicity of dose-escalated salvage radiotherapy for PSMA PET-positive macroscopic prostate cancer recurrence after radical prostatectomy. This evidence concerns the gene FOLH1 and prostate cancer.